Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01988675 · ClinicalTrials.gov registry record
MRI Study of Radiation-Induced Damage to White Matter and Blood-Brain-Barrier
A clinical trial, sponsored by University of Michigan Rogel Cancer Center.
- Completed
- Registry status
- 91
- Enrollment target
NCT01988675 is a clinical trial that has completed, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 91 participants.
The verdict
NCT01988675 has completed, sponsored by University of Michigan Rogel Cancer Center.
- COMPLETED
- Registry status
- 91 participants
- Enrollment target
Study Summary
This is a study to determine if Magnetic Resonance Imaging (MRI) techniques can detect early changes in white matter (in the brain) and the blood-brain barrier resulting from radiation therapy.
Interventions
- BEHAVIORAL Quality of Life Questionnaire
- DEVICE Magnetic Resonance Imaging (MRI) Assessments
- RADIATION Whole Brain Irradiation
- RADIATION Partial Brain Irradiation
- BEHAVIORAL Neuropsychological Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2004-08-26 |
| Est. Completion | 2014-06-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01988675
The ClinicalTrials.gov registry entry for NCT01988675 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 91 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan Rogel Cancer Center, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Quality of Life Questionnaire is the first listed.
NCT01988675 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01988675 about?
NCT01988675 is a clinical study titled "MRI Study of Radiation-Induced Damage to White Matter and Blood-Brain-Barrier". This is a study to determine if Magnetic Resonance Imaging (MRI) techniques can detect early changes in white matter (in the brain) and the blood-brain barrier resulting from radiation therapy.
What is the current status of trial NCT01988675?
This trial is currently completed. The enrollment target is 91 participants. The study started on 2004-08-26. Estimated completion is 2014-06-03.
What interventions are being tested in trial NCT01988675?
The interventions under investigation include: Quality of Life Questionnaire (BEHAVIORAL), Magnetic Resonance Imaging (MRI) Assessments (DEVICE), Whole Brain Irradiation (RADIATION), Partial Brain Irradiation (RADIATION), Neuropsychological Testing (BEHAVIORAL).
Who is sponsoring clinical trial NCT01988675?
This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.